BlackRock Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$615K Sell
13,923
-270,180
-95% -$11.5M ﹤0.01% 2092
2016
Q3
$11.4M Sell
284,103
-1,587
-0.6% -$67.4K 0.01% 804
2016
Q2
$13.6M Sell
285,690
-11,876
-4% -$503K 0.01% 683
2016
Q1
$12.5M Sell
297,566
-2,796
-0.9% -$110K 0.01% 719
2015
Q4
$13.2M Sell
300,362
-6,390
-2% -$277K 0.01% 692
2015
Q3
$14.6M Buy
306,752
+148,382
+94% +$8.15M 0.02% 632
2015
Q2
$9.23M Buy
158,370
+141,114
+818% +$7.61M 0.01% 782
2015
Q1
$871K Buy
17,256
+2,538
+17% +$124K ﹤0.01% 1654
2014
Q4
$662K Sell
14,718
-1,702
-10% -$71.3K ﹤0.01% 1777
2014
Q3
$605K Sell
16,420
-11,541
-41% -$458K ﹤0.01% 1808
2014
Q2
$1.23M Sell
27,961
-141,573
-84% -$6.42M ﹤0.01% 1373
2014
Q1
$7.37M Sell
169,534
-46,462
-22% -$2.07M 0.01% 886
2013
Q4
$9.18M Sell
215,996
-527
-0.2% -$20K 0.01% 818
2013
Q3
$7.35M Buy
216,523
+26
+0% +$848 0.01% 878
2013
Q2
$6.76M Buy
+216,497
New +$7.02M 0.01% 877

Other funds holding CNMD

BlackRock Advisors's CNMD Position: Q4 2016 in Review

BlackRock Advisors reduced its CONMED (CNMD) stake by 95% in Q4 2016, selling an estimated $11.5M and leaving 13,923 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

BlackRock Advisors first reported a position in CNMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.6M in Q3 2015. 147 funds tracked by Wall St. Rank hold CNMD as of Q4 2016.

  • BlackRock Advisors held 13,923 shares of CONMED worth $615K as of Q4 2016.
  • BlackRock Advisors sold 270,180 CONMED shares in Q4 2016, an estimated $11.5M.
  • CONMED made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2092 holding.
  • BlackRock Advisors first reported a position in CONMED in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's CONMED position peaked at $14.6M in Q3 2015.
  • 147 funds tracked by Wall St. Rank held CONMED as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.